Skip to main content

Rite Aid Announces Availability of Opill at All Locations

The first FDA-approved over-the-counter daily birth control pill in the U.S. is now on shelves, available for purchase

Rite Aid Corporation (OTC: RADCQ) today announced Opill, the first daily oral contraceptive FDA-approved for purchase without a prescription, is now available in all stores. Opill is a progestin-only, daily oral contraceptive (birth control pill) that’s safe and effective when used as directed to help prevent pregnancy.

Opill over-the-counter birth control pills are available at Rite Aid for the suggested retail price of $19.99 for a one-month supply and $49.99 for a three-month supply. Both options are available for purchase at Rite Aid stores nationwide and online at RiteAid.com.

“Carrying an over-the-counter FDA-approved birth control pill is an important step in increasing access to reproductive health products and services for women,” said Karen Staniforth, Senior Vice President, Chief Pharmacy Officer at Rite Aid. “Rite Aid remains committed to providing convenient access to customers for all of their health and wellness needs.”

There are no restrictions for purchasing Opill. Rite Aid pharmacists are available to answer any customer questions about Opill.

About Rite Aid Corporation

Rite Aid is a full-service pharmacy committed to improving health outcomes. Rite Aid is defining the modern pharmacy by meeting customer needs with a wide range of solutions that offer convenience, including retail and delivery pharmacy, as well as services offered through our wholly owned subsidiary Bartell Drugs. Regional chain Bartell Drugs has supported the health and wellness needs in the Seattle area for more than 130 years. Rite Aid employs nearly 6,000 pharmacists and operates more than 1,700 retail pharmacy locations across 16 states. For more information, visit www.riteaid.com.

Contacts

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.